GoHealth, Inc. (NASDAQ:GOCO) Short Interest Up 129.2% in June

GoHealth, Inc. (NASDAQ:GOCOGet Free Report) saw a large increase in short interest in June. As of June 15th, there was short interest totaling 1,052,454 shares, an increase of 129.2% from the May 31st total of 459,241 shares. Currently, 5.1% of the company’s stock are short sold. Based on an average trading volume of 1,461,180 shares, the days-to-cover ratio is presently 0.7 days.

Institutional Investors Weigh In On GoHealth

A number of institutional investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. bought a new stake in shares of GoHealth during the fourth quarter valued at approximately $26,000. Benefit Street Partners LLC bought a new position in GoHealth in the 4th quarter valued at approximately $29,000. Charles Schwab Investment Management Inc. boosted its stake in GoHealth by 119.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 26,448 shares of the company’s stock valued at $57,000 after purchasing an additional 14,388 shares during the last quarter. American Century Companies Inc. purchased a new stake in GoHealth during the 2nd quarter valued at $63,000. Finally, Franklin Resources Inc. purchased a new position in shares of GoHealth in the third quarter worth $66,000. Hedge funds and other institutional investors own 24.21% of the company’s stock.

GoHealth Stock Performance

Shares of GOCO traded down $0.01 during trading hours on Monday, hitting $0.30. The company had a trading volume of 2,704,303 shares, compared to its average volume of 916,731. The stock has a market capitalization of $8.60 million, a price-to-earnings ratio of -0.01 and a beta of 1.19. The firm has a fifty day moving average price of $0.73 and a 200-day moving average price of $1.52. GoHealth has a 52-week low of $0.28 and a 52-week high of $7.12.

GoHealth (NASDAQ:GOCOGet Free Report) last announced its quarterly earnings data on Monday, May 18th. The company reported ($2.36) EPS for the quarter, beating the consensus estimate of ($2.40) by $0.04. The company had revenue of $11.91 million for the quarter, compared to the consensus estimate of $16.90 million. GoHealth had a negative net margin of 189.73% and a negative return on equity of 402.70%. Research analysts anticipate that GoHealth will post -9.19 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on GOCO shares. Weiss Ratings reissued a “sell (e+)” rating on shares of GoHealth in a research note on Friday, April 24th. Freedom Capital downgraded shares of GoHealth from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Finally, Noble Financial raised GoHealth to a “strong-buy” rating in a research report on Wednesday, April 1st. One investment analyst has rated the stock with a Strong Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $5.00.

Check Out Our Latest Analysis on GOCO

About GoHealth

(Get Free Report)

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.

Featured Articles

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.